Comparison of Liposomal Bupivacaine Versus Ropivacaine in Alleviating Rebound Pain

Clinical trial NCT07196631 · COMPLETED

Trial details

NCT number: NCT07196631
Sponsor: Liu Jiuhong
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Rebound Pain Liposomal Bupivacaine

Start date: 2025-09-20
Primary completion: 2026-01-01
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.